Combined Mitral and Tricuspid Transcatheter Edge-to-Edge Repair: Evidence, Patient Selection, and Procedural Strategy

Concomitant mitral regurgitation (MR) and tricuspid regurgitation (TR) constitute an interconnected multivalvular syndrome, but correction of MR does not consistently reverse TR. This narrative review examines TR evolution after mitral transcatheter edge-to-edge repair (M-TEER), patient selection, imaging, procedural strategies, and evidence for treatment of both valves. Combined TEER denotes bivalvular treatment, performed during the same session or in stages. Observational cohorts report TR improvement in approximately one-third of broadly selected patients after M-TEER, with substantial variation according to baseline severity, response definition, and follow-up. Persistent or new-onset TR is associated with adverse outcomes; these associations do not establish that subsequent tricuspid intervention improves survival. Comparative registries suggest potential clinical benefit from combined treatment, whereas uncontrolled series primarily establish technical feasibility in selected patients at experienced centers. Treatment timing remains uncertain because randomized comparisons of isolated, same-session, and staged strategies are unavailable. The proposed Heart Team framework integrates lesion-specific indications, anatomical suitability, anticipated TR reversibility, physiological reserve, and patient goals. It is an unvalidated discussion aid rather than a treatment recommendation. Randomized strategy trials are needed to establish incremental clinical benefit, comparative safety, and optimal timing.

Authors

Institutions

Publication Details

Journal
Medicina
Published
2026-11-19
DOI
https://doi.org/10.3390/medicina62112277
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Combined Mitral and Tricuspid Transcatheter Edge-to-Edge Repair: Evidence, Patient Selection, and Procedural Strategy

Vlasis N. Ninios, Grigorios Giamouzis, Maria Kalaitzoglou, John S. Skoularigis et al.
Medicina
Cardiac Valve Diseases and Treatments
article

Combined Mitral and Tricuspid Transcatheter Edge-to-Edge Repair: Evidence, Patient Selection, and Procedural Strategy

Vlasis N. Ninios, Grigorios Giamouzis, Maria Kalaitzoglou, John S. Skoularigis, Apostolia Marvaki, Sotirios Evangelou, Andrew V. Xanthopoulos, Ilias Ninios, Georgios E Papadopoulos, Andreas Ioannides
article en

Abstract

Concomitant mitral regurgitation (MR) and tricuspid regurgitation (TR) constitute an interconnected multivalvular syndrome, but correction of MR does not consistently reverse TR. This narrative review examines TR evolution after mitral transcatheter edge-to-edge repair (M-TEER), patient selection, imaging, procedural strategies, and evidence for treatment of both valves. Combined TEER denotes bivalvular treatment, performed during the same session or in stages. Observational cohorts report TR improvement in approximately one-third of broadly selected patients after M-TEER, with substantial variation according to baseline severity, response definition, and follow-up. Persistent or new-onset TR is associated with adverse outcomes; these associations do not establish that subsequent tricuspid intervention improves survival. Comparative registries suggest potential clinical benefit from combined treatment, whereas uncontrolled series primarily establish technical feasibility in selected patients at experienced centers. Treatment timing remains uncertain because randomized comparisons of isolated, same-session, and staged strategies are unavailable. The proposed Heart Team framework integrates lesion-specific indications, anatomical suitability, anticipated TR reversibility, physiological reserve, and patient goals. It is an unvalidated discussion aid rather than a treatment recommendation. Randomized strategy trials are needed to establish incremental clinical benefit, comparative safety, and optimal timing.

MedicinaVol. 62(11)
University of Thessaly (GR), Interbalkan Medical Center (GR), University Hospital of Larissa (GR)
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon